International Journal of Stem Cell & Regenerative Medicine (IJSCRM) is a peer-reviewed, open-access journal dedicated to publishing high-quality research in the dynamic and rapidly evolving fields of stem cell biology and regenerative medicine. The journal aims to provide a platform for the dissemination of cutting-edge research that contributes to the understanding and advancement of stem cell science and its therapeutic applications.
IJSCRM focuses on all aspects of stem cell research, including the biology, engineering, and clinical application of embryonic, adult, and induced pluripotent stem cells, among others. The journal encourages the submission of manuscripts covering basic science, translational, and clinical research. Topics may range from cellular and molecular mechanisms to gene editing, tissue engineering, and regenerative therapies.
By publishing advancements in stem cell-based therapies, IJSCRM seeks to raise awareness and support the translation of laboratory research into real-world clinical solutions that aim to repair, replace, or regenerate human and animal tissues or organs to restore normal function.
Aim and Scope
The aim of IJSCRM is to promote high-quality publications in the realm of stem cell biology and regenerative medicine, encouraging scientific dialogue and innovation across disciplines. The journal welcomes a variety of article types including original research, review articles, short communications, case studies, and editorials.
Covered areas include but are not limited to:
Researchers from around the world are encouraged to submit original and unpublished work that significantly contributes to the field.
Plagiarism Policy
Authors must ensure that at least 80% of the content in submitted manuscripts is original and not copied from previously published sources. The Results and Conclusion sections must reflect the authors' authentic work, analysis, and findings.
Review Process
IJSCRM follows a double-blind peer review process to uphold the integrity and quality of scholarly publications. This system ensures impartiality by keeping both reviewers and authors anonymous throughout the review process.
A fast-track review option is also available for authors seeking expedited publication. All submissions are evaluated based on their validity, scientific rigor, innovation, and relevance to the field.
For inquiries, please contact: julianaeditor@gmail.com
The aim of IJSCRM is to promote high-quality publications in the realm of stem cell biology and regenerative medicine, encouraging scientific dialogue and innovation across disciplines. The journal welcomes a variety of article types including original research, review articles, short communications, case studies, and editorials.
Covered areas include but are not limited to:
Researchers from around the world are encouraged to submit original and unpublished work that significantly contributes to the field.
Our journal covers a broad spectrum of topics, including but not limited to:
Stem Cells
Embryonic Stem Cells (ESCs)
Induced Pluripotent Stem Cells (iPSCs)
Mesenchymal Stem Cells (MSCs)
Hematopoietic Stem Cells (HSCs)
Neural Stem Cells
Cancer Stem Cells
Regenerative Medicine
Tissue Engineering
Cell-Based Therapy
Gene Therapy
Organoids and 3D Bioprinting
Stem Cell Differentiation and Reprogramming
Stem Cell Transplantation
Clinical Trials in Regenerative Medicine
Personalized & Precision Medicine
Immunotherapy and Immunomodulation
Stem Cell Banking and Cryopreservation
Biomaterials and Scaffold Fabrication
Nanotechnology in Regeneration
CRISPR-Cas9 and Genome Editing
Epigenetics in Stem Cells
Systems Biology and Computational Modeling
Disease Modeling using Stem Cells
Stem Cell Ethics and Regulations
Medicine: Int J Stem Cell Regen Med 2020, 2: 1
Medicine: Int J Stem Cell Regen Med 2020, 2: 1
Medicine: Int J Stem Cell Regen Med 2020, 2: 1
Medicine: Int J Stem Cell Regen Med 2020, 2: 1
Medicine: Int J Stem Cell Regen Med 2021, 3: 1
Medicine: Int J Stem Cell Regen Med 2021, 3: 1
Medicine: Int J Stem Cell Regen Med 2021, 3: 1
Medicine: Int J Stem Cell Regen Med 2022, 4: 1
Medicine: Int J Stem Cell Regen Med 2024, 6: 1
Medicine: Int J Stem Cell Regen Med 2022, 4: 1
Medicine: Int J Stem Cell Regen Med 2022, 4: 1
Medicine: Int J Stem Cell Regen Med 2022, 4: 1
Medicine: Int J Stem Cell Regen Med 2022, 4: 1
Medicine: Int J Stem Cell Regen Med 2022, 4: 1
Medicine: Int J Stem Cell Regen Med 2022, 4: 1
Medicine: Int J Stem Cell Regen Med 2022, 4: 1
Medicine: Int J Stem Cell Regen Med 2023, 5: 1
Medicine: Int J Stem Cell Regen Med 2023, 5: 1
Medicine: Int J Stem Cell Regen Med 2023, 5: 1
Medicine: Int J Stem Cell Regen Med 2023, 5: 1
Medicine: Int J Stem Cell Regen Med 2024, 6: 1
Medicine: Int J Stem Cell Regen Med 2024, 6: 1
Medicine: Int J Stem Cell Regen Med 2025, 7: 1
Medicine: Int J Stem Cell Regen Med 2025, 7: 1
Medicine: Int J Stem Cell Regen Med 2025, 7: 1